
Cadicrit 200mg Injection
Marketer
Cadila Pharmaceuticals Ltd
Salt Composition
Recombinant Human Erythropoietin Alfa (200mg)
Overview Cadicrit 200mg Injection
Epoetin alfa 200mg injection stimulates red blood cell production in the bone marrow. This medication treats anemia stemming from kidney disease, cancer chemotherapy, or HIV medication. Administration, either subcutaneous or intravenous, is determined by your physician and typically performed by a healthcare professional. Dosage is weight-based and varies according to the underlying cause of anemia. Concurrent iron supplementation often enhances treatment efficacy. Store the injection refrigerated but allow it to reach room temperature before use. Common side effects include nausea, vomiting, fever, and elevated blood pressure, along with flu-like symptoms such as headache, fatigue, dizziness, and myalgia. These are often most pronounced initially; however, your doctor can advise on management strategies if they persist. Report any severe adverse events, including convulsions, immediately. Serious thromboembolic events are a potential complication requiring prompt medical attention. Inform your physician of any pre-existing conditions, such as uncontrolled hypertension, cardiovascular disease, or gout, and list all other medications you are taking. Regular blood pressure monitoring and other lab tests are crucial to monitor treatment safety. The impact of this medication on pregnancy is currently unknown; therefore, discuss your pregnancy status, pregnancy plans, or breastfeeding with your doctor before commencing treatment.
Uses of Cadicrit 200mg Injection
Managing Anemia in Cancer Chemotherapy Patients | Addressing Anemia in Chronic Kidney Disease
Major Benefits of Cadicrit 200mg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of Cadicrit 200mg Injection:
- High blood pressure
- Nausea
- Vomiting
- Fever
- Rash
- Joint pain
- Headache
- Insomnia (difficulty in sleeping)
- Chills
- Cough
- Bone pain
- Muscle spasm
- Dizziness
- Vascular occlusion
- Injection site irritation
- Stomatitis (Inflammation of the mouth)
- Weight loss
- Decreased white blood cell count (lymphocytes)
- Increased glucose level in blood
- Blood clot in the blood vessels
How to use Cadicrit 200mg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
How Cadicrit 200mg Injection works:
Cadicrit 200mg Injection, an erythropoietin-based medication, boosts red blood cell production. This is achieved by stimulating the bone marrow's red blood cell synthesis.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Cadicrit 200mg Injection lacks established safety data. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
The use of Cadicrit 200mg Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Using Cadicrit 200mg Injection while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Administering Cadicrit 200mg Injection may induce adverse reactions that can impair driving capabilities.
KidneySAFE IF PRESCRIBED
For patients with kidney impairment, Cadicrit 200mg Injection is considered safe, requiring no dosage modification. However, routine monitoring of renal function is recommended during treatment.
LiverCAUTION
Patients with liver impairment should use Cadicrit 200mg Injection cautiously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Cadicrit 200mg Injection :
Omit Cadicrit 200mg Injection doses only after contacting your physician.
Facts to Know About Cadicrit 200mg Injection
| Label | Value |
|---|---|
| Chemical Category | Amino Acid and Peptide Analogs |
| Developing Habits | No. |
| Treatment Category | KINSHIP |
